Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Zollinger-Ellison Syndrome 1Stomach Ulcer 1Solid Tumours 1Solid Tumor 1Prostate Cancer Patients 1Pharmacokinetics of MDV3100 1Ovarian Neoplasms 1Mouth Neoplasms 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Inflammation 1Hyperuricemia 1Healthy Adult Participants 1Gout 1Esophagitis, Peptic 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Arthritis 1Advanced Solid Tumours 1Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

XENP 1595 2Radiotherapy, Conformal 1Omeprazole 1Naproxen 1Interleukin 1 Receptor Antagonist Protein 1Febuxostat 1Colchicine 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Inflammation × Omeprazole × Clear all
NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed
196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡